Latest reported quarter: Q2, ended Jun 2026 · reported in EUR
Quarter 2026/Q2
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
| Line item | 2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
2025 Q3 (EUR) |
|---|---|---|---|---|---|
| Total Operating Revenue | €8.48B | €8.67B | €32.10B | €7.71B | €8.02B |
| Net Interest Income | €4.55B | €4.20B | €15.69B | €4.27B | €3.92B |
| -Interest Income | €11.15B | €10.82B | €44.46B | €10.95B | €10.97B |
| -Interest Expense | €6.60B | €6.62B | €28.77B | €6.69B | €7.05B |
| Non-Interest Income | €3.93B | €4.46B | €16.41B | €3.44B | €4.11B |
| -Fees and Commissions | €2.29B | €2.81B | €9.05B | €970.00M | €2.65B |
| -Trading Gain Loss | €1.49B | – | €5.34B | – | – |
| -Investment Banking Profit | €567.00M | – | €1.84B | – | – |
| -Other Non-Interest Income | -€401.00M | -€87.00M | €50.00M | -€318.00M | -€34.00M |
| -Gain Loss on Sale of Assets | -€20.00M | €1.74B | €118.00M | -€4.40B | €1.49B |
| Credit Losses Provision | -€460.00M | -€519.00M | -€1.71B | -€395.00M | -€417.00M |
| Non-Interest Expense | €5.27B | €5.02B | €20.29B | €5.13B | €5.04B |
| Selling and Admin Expenses | €5.27B | €5.11B | €18.21B | €2.85B | €5.18B |
| -General & Admin Expense | €5.27B | €5.11B | €18.02B | €2.66B | €5.18B |
| Other Income (Expense) | -€62.00M | -€83.00M | -€369.00M | -€156.00M | -€126.00M |
| Income from Associates & Other Participating Interests | €4.00M | €7.00M | -€6.00M | €13.00M | €19.00M |
| Special Income (Charges) | -€66.00M | -€90.00M | -€363.00M | -€169.00M | -€145.00M |
| -Less:Restructuring and Mergern & Acquisition | -€1.00M | €1.00M | €183.00M | €17.00M | €49.00M |
| -Less:Impairment of Capital Assets | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
| -Less:Other Special Charges | €67.00M | €89.00M | €180.00M | €152.00M | €96.00M |
| Pretax Profit | €2.68B | €3.04B | €9.73B | €2.03B | €2.45B |
| Tax | €774.00M | €867.00M | €2.59B | €453.00M | €626.00M |
| Net Profit | €1.91B | €2.17B | €7.14B | €1.57B | €1.82B |
| Profit from Continuing Operations | €1.91B | €2.17B | €7.14B | €1.57B | €1.82B |
| Minority Interests | €55.00M | €55.00M | €208.00M | €72.00M | €46.00M |
| Net Income to Parent Company | €1.85B | €2.12B | €6.93B | €1.50B | €1.77B |
| Other Preferred Stock Dividends | €210.00M | €206.00M | €760.00M | €155.00M | €209.00M |
| Net Income to Common Stockholders | €1.64B | €1.91B | €6.17B | €1.35B | €1.56B |
| Basic EPS | €0.86 | €0.99 | €3.16 | €0.67 | €0.80 |
| Diluted EPS | €0.85 | €0.98 | €3.09 | €0.67 | €0.78 |
| Dividend Per Share | €1.00 | €0.00 | €0.68 | €0.00 | €0.00 |
| Total Revenue as Reported | – | €8.67B | €32.10B | €7.73B | €8.04B |
| Other Non-Interest Expenses | – | -€89.00M | -€50.00M | €147.00M | -€143.00M |
| -Total Premiums Earned | – | – | €17.00M | – | – |
| Occupancy and Equipment | – | – | €1.46B | – | – |
| Professional Expense and Contract Services Expense | – | – | €671.00M | – | – |
| -Selling & Marketing Expense | – | – | €195.00M | – | – |
| Line item | 2026 Q2 (EUR) |
2026 Q1 (EUR) |
2025 ANNUAL (EUR) |
2025 Q4 (EUR) |
2025 Q3 (EUR) |
|---|---|---|---|---|---|
| Total Assets | €1.52T | €1.48T | €1.44T | €1.44T | €1.39T |
| Cash, Cash Equivalents & Federal Funds Sold | €184.58B | €189.37B | €306.06B | €306.06B | €183.72B |
| -Cash and Cash Equivalents | €140.45B | €149.87B | €171.62B | €171.62B | €148.01B |
| -Money Market Investments | €44.14B | €39.51B | €134.44B | €134.44B | €35.72B |
| Securities Investment | €367.52B | €345.57B | €228.17B | €228.17B | €314.70B |
| -Trading Securities | €176.59B | €172.47B | €141.01B | €141.01B | €161.77B |
| -Available for Sale Securities | €142.39B | €126.10B | €49.07B | €49.07B | €110.87B |
| -Short Term Investments | €48.54B | €47.01B | €38.08B | €38.08B | €42.06B |
| Long Term Equity Investment | €984.00M | €996.00M | €924.00M | €924.00M | €921.00M |
| Derivative Assets | €275.75B | €271.40B | €241.33B | €241.33B | €232.07B |
| Securities Lent | €6.00M | €6.00M | €16.52B | €16.52B | €24.00M |
| Net Loan | €484.61B | €479.73B | €493.22B | €493.22B | €469.87B |
| -Gross Loan | €490.91B | €486.06B | €499.27B | €499.27B | €475.73B |
| -Allowance for Loans and Lease Losses | €6.30B | €6.33B | €6.05B | €6.05B | €5.86B |
| Receivables | €1.57B | €1.60B | €111.58B | €111.58B | €1.44B |
| -Other Receivables | €1.57B | €1.60B | €1.61B | €1.61B | €1.44B |
| Net PPE | €5.86B | €5.93B | €5.92B | €5.92B | €6.01B |
| Goodwill and Other Intangible Assets | €7.84B | €7.75B | €7.56B | €7.56B | €7.50B |
| Deferred Assets | €6.29B | €6.42B | €6.54B | €6.54B | €6.73B |
| Other Assets | €186.48B | €174.25B | €17.21B | €17.21B | €168.26B |
| Total Liabilities | €1.44T | €1.40T | €1.35T | €1.35T | €1.31T |
| Total Deposits | €698.19B | €686.66B | €691.83B | €691.83B | €662.96B |
| Federal Funds Purchased and Securities Sold Under Agreement to Repurchase | €3.69B | €2.22B | €90.35B | €90.35B | €3.20B |
| Derivative Product Liabilities | €260.11B | €253.47B | €225.78B | €225.78B | €213.58B |
| Short-Term Debt and Capital Lease Obligation | €24.85B | €24.26B | €18.20B | €18.20B | €14.86B |
| -Current Debt | €24.85B | €24.26B | €18.20B | €18.20B | €14.86B |
| Derivative liabilities | €2.00M | €2.00M | €2.00M | €2.00M | €2.00M |
| Trading Liabilities | €192.38B | €171.51B | €44.46B | €44.46B | €157.91B |
| Payables | €936.00M | €839.00M | €112.86B | €112.86B | €932.00M |
| -Total Tax Payable | €936.00M | €839.00M | €694.00M | €694.00M | €932.00M |
| Long Term Debt and Capital Lease Obligation | €111.35B | €113.16B | €146.25B | €146.25B | €113.77B |
| -Long Term Debt | €111.35B | €113.16B | €142.06B | €142.06B | €113.77B |
| Non-Current Liabilities | €2.16B | €2.31B | €2.41B | €2.41B | €2.39B |
| Non-Current Deferred Liabilities | €669.00M | €665.00M | €623.00M | €623.00M | €604.00M |
| Convertible preferred securities | €283.00M | €282.00M | €283.00M | €283.00M | €284.00M |
| Other Liabilities | €146.46B | €148.01B | €21.82B | €21.82B | €141.88B |
| Total Equity | €80.40B | €79.65B | €80.20B | €80.20B | €78.88B |
| Stockholders' Equity | €78.82B | €78.01B | €78.64B | €78.64B | €77.38B |
| Capital Stock | €4.89B | €4.89B | €4.89B | €4.89B | €4.99B |
| -Common Stock | €4.89B | €4.89B | €4.89B | €4.89B | €4.99B |
| Additional Paid-In Capital | €37.76B | €37.62B | €38.28B | €38.28B | €38.96B |
| Retained Earnings | €29.25B | €30.12B | €28.10B | €28.10B | €26.59B |
| Less: Treasury Stock | €841.00M | €772.00M | €185.00M | €185.00M | €942.00M |
| Gains/Losses Not Affecting Retained Earnings | -€4.06B | -€4.33B | -€4.15B | -€4.15B | -€4.07B |
| Other Equity Interests | €11.82B | €10.49B | €11.71B | €11.71B | €11.86B |
| Minority Interests | €1.58B | €1.63B | €1.56B | €1.56B | €1.50B |
| -Accounts Receivable | – | – | €109.97B | €109.97B | – |
| -Gross PPE | – | – | €13.51B | €13.51B | – |
| -Accumulated Depreciation | – | – | -€7.59B | -€7.59B | – |
| -Goodwill | – | – | €2.74B | €2.74B | – |
| -Other Intangible Assets | – | – | €4.83B | €4.83B | – |
| Assets Held for Sale | – | – | €35.00M | €35.00M | – |
| -Accounts Payable | – | – | €112.17B | €112.17B | – |
| -Long Term Capital Lease Obligation | – | – | €4.19B | €4.19B | – |
| Liabilities of Discontinued Operations | – | – | €0.00 | €0.00 | – |
| Line item | 2025 ANNUAL (EUR) |
2024 ANNUAL (EUR) |
2023 ANNUAL (EUR) |
2022 ANNUAL (EUR) |
2021 ANNUAL (EUR) |
|---|---|---|---|---|---|
| Operating Cash Flow | €47.06B | -€28.58B | €5.61B | -€2.11B | -€2.95B |
| Net cash flow from continuing operations | €47.06B | -€28.58B | €5.61B | -€2.11B | -€2.95B |
| Net Income from Continuing Operations | €7.14B | €3.51B | €4.89B | €5.66B | €2.51B |
| Gain/Loss from Continuing Operations | -€57.00M | -€72.00M | €23.00M | -€1.00M | -€473.00M |
| Deferred Tax | €837.00M | €473.00M | -€553.00M | -€852.00M | €19.00M |
| Other Non-Cash Items | -€15.00M | -€4.00M | €218.00M | -€117.00M | €262.00M |
| Change in Working Capital | €34.65B | -€37.70B | -€3.59B | -€11.56B | -€9.35B |
| -Change in Loans | €8.99B | -€31.28B | €381.00M | -€24.29B | -€50.49B |
| -Change in Other Current Assets | -€52.23B | €13.99B | -€1.38B | -€459.00M | €8.05B |
| -Change in Other Current Liabilities | €48.76B | -€19.80B | €777.00M | €12.38B | -€17.82B |
| -Change in Other Working Capital | €29.13B | -€613.00M | -€3.36B | €813.00M | €50.91B |
| Net cash flow from investing | -€26.31B | -€6.78B | -€2.58B | -€17.18B | €23.60B |
| Net Cash Flow from Continuing Investing Activities | -€26.31B | -€6.78B | -€2.58B | -€17.18B | €23.60B |
| Net PPE Purchase and Sale | -€425.00M | -€508.00M | -€389.00M | -€315.00M | -€436.00M |
| Net Business Purchase and Sale | €0.00 | €3.00M | -€361.00M | €439.00M | -€5.00M |
| Net Investment Purchase and Sale | -€24.45B | -€4.90B | -€439.00M | -€16.21B | €25.05B |
| Net Other Investing Changes | -€1.44B | -€1.37B | -€1.39B | -€1.09B | -€1.01B |
| Financing Cash Flow | -€6.83B | -€646.00M | -€2.85B | €614.00M | €1.63B |
| Net Cash Flow from Continuing Financing Activities | -€6.84B | -€647.00M | -€2.85B | €614.00M | €1.63B |
| Net Issuance Payments of Debt | -€3.17B | -€685.00M | -€573.00M | €2.02B | €425.00M |
| Net Common Stock Issuance | -€1.62B | -€1.13B | -€857.00M | -€695.00M | -€311.00M |
| Net Preferred Stock Issuance | -€6.00M | -€6.00M | -€225.00M | €0.00 | -€504.00M |
| Cash Dividends Paid | -€1.32B | -€883.00M | -€610.00M | -€406.00M | €0.00 |
| Net Other Financing Activities | -€725.00M | €2.05B | -€587.00M | -€304.00M | €2.02B |
| Ending Cash Balance | €138.28B | €130.67B | €163.77B | €165.63B | €179.95B |
| Net Change in Cash | €13.92B | -€36.01B | €178.00M | -€18.67B | €22.27B |
| Beginning Cash Balance | €130.67B | €163.77B | €165.63B | €179.95B | €156.33B |
| Effect of Exchange Rate Changes | -€6.31B | €2.91B | -€2.04B | €4.35B | €1.35B |
| Free Cash Flow | €46.62B | -€29.11B | €5.18B | -€2.45B | -€3.50B |